Nintendo Wii Could Be Therapy for Stroke VictimsVideo
Categories
- Allergy
- Alzheimer's Disease
- Arthritis
- Asthma
- Breast Cancer
- Cardio Health
- Cholesterol
- Cold and Flu
- Colon Cancer
- Diabetes
- Dieting
- Epilepsy
- Hair Loss
- Headache
- Heartburn
- HIV & AIDS
- Kidney Health
- Leukemia
- Lung Cancer
- Lymphoma
- Multiple Sclerosis
- Men's Health
- Mental Health
- Nutrition
- Osteoporosis
- Parkinson's Disease
- Prostate Health
- Skin Health
- Sleep Disorders
- Women's Health
- General
Researchers Propose Improved Cervical Cancer Screening
Posted on 09/21/2009, 12:00
By -- Robert Preidt
New method uses risk estimation to guide management, experts say
MONDAY, Sept. 21 (HealthDay News) -- A new tool to determine a woman's risk of developing cervical cancer is being developed by researchers at the U.S. National Cancer Institute.
Their proposal appears as a Keynote Comment article in the Sept. 20 online edition and in the November print issue of The Lancet Oncology.
Cytology (cell testing) is the current first-line method of cervical cancer screening. If the results are abnormal, women undergo repeat cytology, or carcinogenic human papillomavirus (HPV) DNA testing, or are referred directly for a colposcopy, during which biopsies are taken from apparent lesions.
Complex consensus management algorithms are used to determine treatment, but these algorithms are becoming increasingly complex as new technologies become available, the researchers said in a news release from the journal.
"Instead of providing clinicians with algorithms, we propose to provide clinicians with their patient's risk of developing cervical cancer. As a surrogate for cervical cancer, we propose to use cervical precancer, best defined as histological cervical intraepithelial neoplasia grade 3 (CIN3) or more severe (CIN3+), or less precisely by CIN2+, a common treatment threshold," wrote Hormuzd A. Katki and colleagues.
The study authors noted that large amounts of data on risk of cervical precancer are being produced by clinical trials. This risk can be calculated when women are screened for cervical cancer, for those sent immediately to colposcopy, or at one-year, two-year, or three-year follow-up intervals.
"The risk of cervical precancer is a unifying concept to guide management, regardless of which combination of tests a woman has undergone, because risk of cervical precancer boils down to a complex battery of test results over time into a single percentage that forms a basis for action," the research team wrote.
More information
The American Cancer Society has more about cervical cancer.
SOURCE: The Lancet Oncology, news release, Sept. 20, 2009
Copyright © 2009 ScoutNews, LLC. All rights reserved.
BigHealthTree.com Disclaimer
Bighealthtree.com Does Not Provide Medical Advice. This site, including the above information, is for informational purposes only and is not a substitute for professional medical or health advice. Always seek the advice of your physician or a qualified health or medical professional before starting any new treatment, changing existing treatment, or altering your current exercise and/or diet program. If you think you are having a medical emergency, call 911 (or the emergency services in your area) or your doctor immediately.
Single Men Have An Increased Risk for Stroke
Fatty Foods Could Lead to Stroke in Older Women
Woman Gives Birth After Ovary Transplant
Cancer Foundation Raises Money for Neuroblastoma
Too Much Weight Gain During Pregnancy Could Lead to Diabetes
New CT Scanners Use 90% Less Radiation
Music Education Can Shape a Child's Sensory System
Food Warning Labels Could Help Prevent Choking Hazards
Acupuncture May Relieve Depression in Pregnant Women
The Economy Could Lower Life Expectancy
HPV Can Be Studied On Dolphins
Social Support is Good for Women After a Heart Attack
Happiness Can Prevent Heart Problems
Frying With Gas

Comments (0):
Be the first to comment on this article.
Post a comment